Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02599090
What this trial is testing

Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00352313
What this trial is testing

ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC) 82
Testing effectiveness (Phase 2)Study completedNCT00905060
What this trial is testing

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 70
Early research (Phase 1)Ended earlyNCT05627323
What this trial is testing

CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
Chimeric Therapeutics 1
Not applicableEnded earlyNCT03717142
What this trial is testing

Feasibility of the LUM Imaging System for Detection of Cancer to the Brain

Who this might be right for
Low Grade Glioma of BrainGlioblastomaMetastasis to Brain
Lumicell, Inc. 4
Not applicableStudy completedNCT03626896
What this trial is testing

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

Who this might be right for
Glioblastoma MultiformeBrain TumorGlioblastoma+3 more
NaviFUS Corporation 6
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Testing effectiveness (Phase 2)Study completedNCT00302159
What this trial is testing

Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors

Who this might be right for
High Grade GliomasBrain Tumors
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00070161
What this trial is testing

Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsRadiation Toxicity
Wake Forest University Health Sciences 68
Not applicableActive Not RecruitingNCT06649591
What this trial is testing

Expert Consensus and Artificial Intelligence in Medical Decision Making in Patients with Malignant Brain Tumors

Who this might be right for
Malignant Brain Tumors
Tufts Medical Center 225
Early research (Phase 1)Ended earlyNCT01122888
What this trial is testing

Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+2 more
National Cancer Institute (NCI) 41
Not applicableWithdrawnNCT00005790
What this trial is testing

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University
Early research (Phase 1)Ended earlyNCT02648633
What this trial is testing

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
University of Virginia 4
Not applicableStudy completedNCT05015543
What this trial is testing

Physical Training in Glioblastoma Patients During Cytotoxic Therapy

Who this might be right for
Glioblastoma
University Hospital Muenster 54
Not applicableStudy completedNCT00009035
What this trial is testing

Natural History of Patients With Brain and Spinal Cord Tumors

Who this might be right for
AstrocytomaOligodendrogliomaGlioblastoma+2 more
National Cancer Institute (NCI) 3,050
Testing effectiveness (Phase 2)Study completedNCT00070525
What this trial is testing

Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma

Who this might be right for
Childhood High-grade Cerebral AstrocytomaChildhood OligodendrogliomaRecurrent Childhood Brain Stem Glioma+5 more
National Cancer Institute (NCI) 90
Early research (Phase 1)UnknownNCT00002647
What this trial is testing

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Medical College of Wisconsin 24
Testing effectiveness (Phase 2)Ended earlyNCT01582152
What this trial is testing

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Who this might be right for
Brain NeoplasmsCentral Nervous System Neoplasms
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT02986178
What this trial is testing

Lerapolturev in Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Istari Oncology, Inc. 121
Not applicableActive Not RecruitingNCT07420543
What this trial is testing

Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach

Who this might be right for
Brain Tumors and/or Solid Tumors IncludingGlioblastomaGlioblastoma (GBM)+1 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 30
Next Page